Johnson & Johnson
-
Johnson & Johnson (JNJ) Q3 Earnings: EPS $2.59 beats expectations, Revenue $25.4 billion beats expectations
EPS: $2.59 vs. $2.52 expected Revenue: $25.4 billion vs. $25.38 billion expected Reporting Period: Q3 FY2026 (ended September 28, 2026) Release Date: October 13, 2026
-
Johnson & Johnson Plans Orthopedics Business Separation by Mid-2027, OTTAVA Surgical Robot Showing Positive Feedback
Johnson & Johnson (JNJ) MedTech Chairman Tim Schmid noted the planned separation of the company's orthopedics business, expected around mid-2027, with various separation structures being evaluated. He
-
Johnson & Johnson proposes a $5.5 billion settlement to resolve approximately 76,000 talc-related ovarian cancer lawsuits.
The proposed agreement, which requires 95% participation from eligible claimants, aims to convert an unpredictable legal risk into a more manageable financial obligation for the company. However, it d
-
Jim Cramer says Johnson & Johnson's talc settlement is positive for the stock
Financial commentator Jim Cramer stated that Johnson & Johnson's (J&J) recent talc settlement is beneficial for the company's stock, which he believes already has strong momentum. Cramer also characte
-
Johnson & Johnson (JNJ) Q3 Earnings: EPS $2.59 beats expectations, Revenue $25.4 billion beats expectations
EPS: $2.59 vs. $2.52 expected Revenue: $25.4 billion vs. $25.38 billion expected Reporting Period: Q3 FY2026 (ended September 28, 2026) Release Date: October 13, 2026
-
Johnson & Johnson Plans Orthopedics Business Separation by Mid-2027, OTTAVA Surgical Robot Showing Positive Feedback
Johnson & Johnson (JNJ) MedTech Chairman Tim Schmid noted the planned separation of the company's orthopedics business, expected around mid-2027, with various separation structures being evaluated. He
-
Johnson & Johnson proposes a $5.5 billion settlement to resolve approximately 76,000 talc-related ovarian cancer lawsuits.
The proposed agreement, which requires 95% participation from eligible claimants, aims to convert an unpredictable legal risk into a more manageable financial obligation for the company. However, it d
-
Jim Cramer says Johnson & Johnson's talc settlement is positive for the stock
Financial commentator Jim Cramer stated that Johnson & Johnson's (J&J) recent talc settlement is beneficial for the company's stock, which he believes already has strong momentum. Cramer also characte
- No data
Johnson & Johnson
24H Trending
-
1
AI Tokens Explained: Definition, Key Projects, and Market Outlook for Artificial Intelligence Cryptocurrencies
-
2
What is NBM Coin (NFTBlackmarket)? Status and Trading Channels Analysis
-
3
Verizon Communications Inc. (VZ) Q3 Earnings Report Earnings Per Share (EPS): $1.31, market expectation $1.27 Revenue: $34.31 billion, market expectation $34.77 billion Reporting Period: FY2026 Q3 (ended September 30, 2026) Release Date: October 26, 2026
-
4
Brent crude prices fell below $110/barrel, down over 6% from Friday's high
-
5
Which Platforms Allow Bitcoin Purchases Now? A Guide to Choosing Bitcoin Trading Apps
-
6
Virtual Currency Exchange Review: Compliance and Risk Boundaries of Major Global Platforms
-
7
What is EURe? An Analysis of the Euro Stablecoin EURe's Features, Uses, and Trading Channels
-
8
Israel will hold general elections on Tuesday, with war, security, the economy, and coalition formation being the main issues
-
9
Will Cryptocurrencies Disappear? A Comprehensive Analysis of Their Survival Prospects and Challenges
-
10
Global Crypto Exchange Analysis: Largest Platforms and Best Application Choices
Markets Today
Recommended Reading





